Polpharma Biologics Rebrands As New Warsaw Site Is Validated

First Production Run Expected In Mid-2021

 
• By Dean Rudge
  
Europe
Polpharma Biologics recently brought under its brand the Bioceros R&D site in Utrecht • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products